D
D. Arigoni
Researcher at Ciba Specialty Chemicals
Publications - 30
Citations - 1347
D. Arigoni is an academic researcher from Ciba Specialty Chemicals. The author has contributed to research in topics: Limonin & Aldosterone. The author has an hindex of 19, co-authored 30 publications receiving 1324 citations. Previous affiliations of D. Arigoni include Novartis.
Papers
More filters
Journal ArticleDOI
Zur Kenntnis der Triterpene. 190. Mitteilung. Eine stereochemische Interpretation der biogenetischen Isoprenregel bei den Triterpenen
TL;DR: In this article, the biogenetic isoprene rule in its application to the triterpenes is discussed from a stereochemical standpoint, and a scheme has been developed leading from squalene to the formulae of the basic representatives of all known cyclic triterpene groups in their full structural and configurational detail.
Journal ArticleDOI
The constitution of limonin
D. Arigoni,D. H. R. Barton,E. J. Corey,O. Jeger,L. Caglioti,Sukh Dev,P. G. Ferrini,E. R. Glazier,A. Melera,S. K. Pradhan,K. Schaffner,S. Sternhell,J. F. Templeton,S. Tobinaga +13 more
Journal ArticleDOI
Über Steroide und Sexualhormone. 211. Mitteilung. Direkte Einführung einer Sauerstoffunktion in die Methylgruppe C-18 im intakten Steroidgerüst
TL;DR: The main product of this reaction is the 18,20β-oxido compound I11 as proved by its conversion into the lactone V and the lactol VI as discussed by the authors.
Journal ArticleDOI
Zur Kenntnis der Sesquiterpene und Azulene. 126. Mitteilung. Über die Inhaltsstoffe der Asa foetida I. Farnesiferol A
TL;DR: Farnesiferol A (I) is a mixed ether of umbelliferone with a sesquiterpene moiety of the bicyclofarnesylic type as mentioned in this paper.
Journal ArticleDOI
Zur Kenntnis der Sesquiterpene und Azulene. 127. Mitteilung. Über die Inhaltsstoffe der Asa foetida II. Farnesiferol B und C
TL;DR: In this article, Farnesiferol B and C, two isomeric C24H30O4 compounds previously isolated from Asa foetida (Umbelliferae), were derived on the basis of degradative work and physical evidence.